Longfellow Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$610K Hold
2,084
0.13% 105
2025
Q4
$731K Buy
2,084
+8
+0.4% +$2.7K 0.16% 94
2025
Q3
$671K Buy
2,076
+968
+87% +$301K 0.16% 103
2025
Q2
$431K Buy
1,108
+1,101
+15,729% +$443K 0.11% 117
2025
Q1
$3.04K Hold
7
﹤0.01% 211
2024
Q4
$2.58K Hold
7
﹤0.01% 220
2024
Q3
$3.64K Hold
7
﹤0.01% 201
2024
Q2
$3.79K Hold
7
﹤0.01% 192
2024
Q1
$3.63K Hold
7
﹤0.01% 210
2023
Q4
$3.3K Hold
7
﹤0.01% 187
2023
Q3
$3.05K Buy
7
+2
+40% +$907 ﹤0.01% 177
2023
Q2
$2.22K Buy
+5
New +$2.31K ﹤0.01% 216

Other funds holding ELV

Longfellow Investment Management's ELV Position: Q1 2026 in Review

Longfellow Investment Management held its Elevance Health (ELV) position steady in Q1 2026 at 2,084 shares worth $610K. The position accounts for 0.13% of the portfolio, ranked #105.

Longfellow Investment Management first reported a position in ELV in Q2 2023 and has held it in 12 quarters since. The position peaked at $731K in Q4 2025. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Longfellow Investment Management held 2,084 shares of Elevance Health worth $610K as of Q1 2026.
  • Longfellow Investment Management left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up 0.13% of Longfellow Investment Management's portfolio in Q1 2026, its #105 holding.
  • Longfellow Investment Management first reported a position in Elevance Health in Q2 2023 and has held it in 12 quarters since.
  • Longfellow Investment Management's Elevance Health position peaked at $731K in Q4 2025.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Longfellow Investment Management's 13F filing for Q1 2026, filed 12 May 2026.